Headline News Archive
Click on title to read the full article.
In the Pipeline: Cabozantinib Shown to Control Tumors and Bone Metastases
May 22, 2020
By Jennie Smith
The experimental drug cabozantinib achieved high rates of disease control and shrunk or eliminated bone metastases in a range of advanced cancers, according to results from a phase II trial.
Blood Test For Breast Cancer?
May 22, 2020
Researchers at Georgetown Lombardi Comprehensive Cancer Center say the amount of circulating tumor cells (CTCs) in the blood is a "powerful predictor" and reliable for aiding physicians when they assess treatment benefit for patients with metastatic breast cancer.
Nexavar In Combination With Chemotherapy Improves Progression-Free Survival In Patients With Advanced Breast Cancer In Phase 2 S
May 22, 2020
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from a Phase 2b trial evaluating Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic breast cancer
Genentech Appeals to FDAs Regulatory Flexibility on Avastin
May 18, 2020
By Mary Jo Laffler
Genentech’s advance summary of evidence and arguments for the Food and Drug Administration’s upcoming hearing on the agency’s proposed withdrawal of the metastatic breast cancer approval for Avastin shows that the company is trying to keep the focus on the additional confirmatory trial it proposes to conduct.
Should a Mother Lose Custody of Her Kids Because She Has Cancer?
May 12, 2020
By Bonnie Rochman
Alaina Giordano was already engaged in a battle royale, fighting Stage 4 breast cancer, when her struggle intensified recently: a judge ruled that the N.C. woman must give up custody of her two children to her husband, who lives in Chicago, in part because "children who have a parent with cancer need more contact with the non-ill parent."
Breast cancer cells utilize tissue stem cell EMT for tumor metastasis
May 9, 2020
By University of North Carolina School of Medicine
Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer. The scientific first opens the door for developing novel targeted therapies aimed at triple negative breast cancer.
4th International Symposium On Cancer Metastasis And The Lymphovascular System
May 9, 2020
By California Pacific Medical Center
Novel therapies for breast cancer, melanoma, and other solid tumors, and discussions of the microenvironment around metastatic disease, will be among the topics covered in presentations at the 4th International Symposium on Cancer Metastasis and the Lymphovascular System
Chemo Combo for Metastatic Breast Cancer May Help Previously Treated Patients
May 3, 2020
By Anne Azvolinsky, PhD
A 33-patient Phase 1/2 study in Europe published in the European Journal of Cancer (doi:10.1016/j.ejca.2011.01.001) has shown that a new chemotherapy combo of a novel taxoid, cabazitaxel, and capectiabine shows promise in previously treated metastatic breast cancer patients. The combination also had a good safety profile, which means that it warrants more extensive clinical trials.
Headline News Archive
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- October 2007
- September 2007